—

Eli Lilly and Company (LLY) — Technical state

As of 2026-10-06 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

Target raised to $1430

Morgan Stanley lifted its price target to $1430 from $1419 (2026-10-07).

The moving-average stack

FAQ · from the current data · as of 2026-10-06

Quick answers

What is the current Closelooknet signal on LLY?

Target raised to $1430 — Morgan Stanley lifted its price target to $1430 from $1419 (2026-10-07). As of 2026-10-06; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is LLY above its 50-day and 200-day moving averages?

As of 2026-10-06, Eli Lilly and Company trades -1.5% below its 50-day and +7.7% above its 200-day average, with the 20-day +0.4% away.

How far is LLY from its 52-week high?

10.5% below the 52-week high and 63.1% above the 52-week low, as of 2026-10-06.

Mentioned on Closelooknet

Where LLY appears in the diary — 2 pieces, newest first. Every link is our own writing.

Dailies

Related in the Closelooknet universe

same Closelooknet index seat first, then Drug Manufacturers - General. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.